ESRU:LSE:LSE-Amundi Index Solutions - Amundi MSCI Europe SRI PAB UCITS ETF DR C USD (USD)

ETF | Others |

Last Closing

USD 95.78

Change

0.00 (0.00)%

Market Cap

N/A

Volume

210.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+6.50 (+3.14%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.17 (-1.15%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.12 (-0.65%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+7.95 (+6.53%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.23 (-0.72%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.43%)

USD 266.08B
0QZO:LSE 0QZO

+1.10 (+1.00%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.50 (-0.98%)

USD 202.26B
0R24:LSE Intel Corp.

+0.71 (+3.22%)

USD 196.14B

ETFs Containing ESRU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.14% 82% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.14% 82% B 77% C+
Trailing 12 Months  
Capital Gain 4.53% 48% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.53% 43% F 52% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.41% 57% F 61% D-
Dividend Return 7.41% 56% F 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.05% 71% C- 84% B
Risk Adjusted Return 92.05% 85% B 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike